Back to Search
Start Over
Recent Advances in the Management of Neovascular Glaucoma
- Source :
- Seminars in Ophthalmology. 28:165-172
- Publication Year :
- 2013
- Publisher :
- Informa UK Limited, 2013.
-
Abstract
- The development of anti-vascular endothelial growth factor (VEGF) molecules has expanded the range of available treatment options for many ocular diseases, including neovascular glaucoma (NVG). A number of studies have explored the use of anti-VEGF agents as stand-alone or adjunctive treatment for NVG. Although no large, prospective, randomized trials have been performed to date, the growing body of knowledge suggests that anti-VEGF agents are effective at reversing iris and angle neovascularization and lowering intraocular pressure in patients with NVG. Response to a single injection is typically temporary; therefore, laser or incisional surgery is still necessary in most cases. Future research is needed to determine the optimal agent, dose, route of administration, and timing of treatment either as monotherapy or coupled with other medical and/or surgical interventions.
- Subjects :
- Vascular Endothelial Growth Factor A
medicine.medical_specialty
Intraocular pressure
genetic structures
Iris
Glaucoma
Angiogenesis Inhibitors
Neovascular glaucoma
law.invention
Neovascularization
Route of administration
Randomized controlled trial
law
Ophthalmology
Humans
Medicine
In patient
Neovascularization, Pathologic
business.industry
General Medicine
medicine.disease
eye diseases
Glaucoma, Neovascular
Filtering Surgery
Adjunctive treatment
Laser Therapy
medicine.symptom
business
Subjects
Details
- ISSN :
- 17445205 and 08820538
- Volume :
- 28
- Database :
- OpenAIRE
- Journal :
- Seminars in Ophthalmology
- Accession number :
- edsair.doi.dedup.....1848ed40d9b4f851ca29895cffdc3a95